Canadian Blood Service: SARS-CoV-2 Seroprevalence Study

Overview

Acronym
CBS
Website
CBS
Investigators
  • Dr. Sheila O'brien

    Canadian Blood Services

  • Dr. Chantale Pambrun

    Centre for Innovation, Canadian Blood Services

Contacts
  • Dr. Sheila O'brien

    Canadian Blood Services

General Design

Study design
Cross-sectional
Start Year
2020
General Information on Follow Up (profile, frequency)
At phase I participants were seen from May 9, 2020 until July 21, 2020. As of August 2020, only samples from the last 2 weeks of each month are tested. As of December 2020, all samples are sampled once again. Additional phases of testing are anticipated.
Recruitment Target
  • Individuals
Number of Participants
No Limit

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Population

CBS population

Selection Criteria

Minimum age
17
Countries
  • Canada
Territory
British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador
Health Status
  • In good health
Other Criteria
Must meet all criteria to donate blood.

Sources of Recruitment

Specific Population
  • Other specific population : Blood donors
Supplementary Information
Participants were regular blood donors from a combination of fixed and mobile sites in all larger cities and most urban areas. This project uses retention samples from blood donations that would normally be discarded.

Sample Size

Number of Participants
No Limit

Data Collection Events

# Name Description Start End
0 CBS - Phase 1 2020 (May) Ongoing

Individual Studies Included

Acronym Name Study design Participants Countries

Harmonization Projects Included

Acronym Name

Networks

Acronym Name Studies

Datasets

Name Type Data Collection Events Variables
Last Update: 2021-04-29 22:01